SEC Form 4 · accession 0001003642-16-000026
Impax Laboratories, LLC · IPXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rick Bierly
Director
Period of report
Aug 19, 2016
Accepted (ET)
Aug 22, 2016 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001003642
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2016 | A | 4,895 | $0.00 | A | 4,895 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right-to-Buy)F1 | $23.35 | Aug 19, 2016 | A | 11,840 | A | — | Aug 19, 2026 | Common Stock | 11,840 | 11,840 | D |
Explanation of responses
- F1The option fully vests on the earlier of (i) August 19, 2017, which is the first anniversary of the date of grant and (ii) one day before the date of the Company's next annual meeting of stockholders.
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.